Showing 28,921 - 28,940 results of 48,330 for search '(( 12 we decrease ) OR ( 50 ((((nn decrease) OR (mean decrease))) OR (a decrease)) ))', query time: 1.19s Refine Results
  1. 28921

    Supplemental Material for Zhou et al., 2020 by Wei Zhou (8087560)

    Published 2019
    “…p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 11.0px Helvetica} <p>Amino acid substitutions are commonly found in human transcription factors, yet the functional consequence of much of this variation remains unknown, even in wellcharacterized DNA-binding domains. Here, we examine how six single amino acid variants in the DNA-binding domain of Ste12 – a yeast transcription factor regulating mating and invasion – alter Ste12 genome binding, motif recognition and gene expression to yield markedly different phenotypes. …”
  2. 28922

    Metabolomic and chemogenomic profiling. by Wesley C. Van Voorhis (191219)

    Published 2016
    “…Six of seven compounds (indicated in red) reported to target <i>Pf</i>ATP4 [<a href="http://www.plospathogens.org/article/info:doi/10.1371/journal.ppat.1005763#ppat.1005763.ref025" target="_blank">25</a>] showed a distinct metabolic response characterized by the accumulation of dNTPs and a decrease in hemoglobin-derived peptides. …”
  3. 28923
  4. 28924

    Data_Sheet_3_Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing.PDF by Saria Mcheik (3204414)

    Published 2019
    “…We demonstrate that expression of CCR7 in B cells is involved in the selective inactivation of CXCR4, and that mature B cells from CCR7<sup>−/−</sup> mice display higher responsiveness to CXCL12 and improved retention in the bone marrow. …”
  5. 28925

    Data_Sheet_2_Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing.PDF by Saria Mcheik (3204414)

    Published 2019
    “…We demonstrate that expression of CCR7 in B cells is involved in the selective inactivation of CXCR4, and that mature B cells from CCR7<sup>−/−</sup> mice display higher responsiveness to CXCL12 and improved retention in the bone marrow. …”
  6. 28926
  7. 28927
  8. 28928

    Data_Sheet_1_Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing.PDF by Saria Mcheik (3204414)

    Published 2019
    “…We demonstrate that expression of CCR7 in B cells is involved in the selective inactivation of CXCR4, and that mature B cells from CCR7<sup>−/−</sup> mice display higher responsiveness to CXCL12 and improved retention in the bone marrow. …”
  9. 28929
  10. 28930

    DataSheet_1_Differences in Prostate Cancer Incidence and Mortality in Lower Saxony (Germany) and Groningen Province (Netherlands): Potential Impact of Prostate-Specific Antigen Tes... by Sanny Kappen (10889607)

    Published 2021
    “…Between 2003 and 2012, the average annual percentage change (AAPC) in PCa incidence rates did not change significantly in either Lower Saxony (−1.8%, 95% CI −3.5, 0.0) or Groningen (0.2%, 95% CI −5.0, 5.7). In contrast, the AAPC in mortality rate decreased significantly during the same time period in Lower Saxony (−2.5%, 95% CI −3.0, −2.0) but not in Groningen (0.1%, 95% CI −2.4, 2.6).…”
  11. 28931
  12. 28932
  13. 28933

    Plot of the between cluster inertia for group 2. by Pasquale Musso (12400652)

    Published 2022
    “…<p>Between cluster inertia (or inertia gain) smoothly decreases when the number of clusters increases and we cannot identify a clear cutoff. …”
  14. 28934

    Supplementary Material for: Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease by Martin E.R. (3859435)

    Published 2017
    “…All subjects received low-dose supplemental oral iron (50 mg daily). The primary endpoint was the mean absolute change in hemoglobin (Hb) from baseline to the end of treatment. …”
  15. 28935

    Audio_2_Retroauricular/Transcranial Color-Coded Doppler Ultrasound Approach in Junction With Ipsilateral Neck Compression on Real-Time Hydroacoustic Variation of Venous Pulsatile T... by Xiuli Gao (2036302)

    Published 2022
    “…When the ipsilateral IJV was compressed, PT disappeared, as the mean velocity of mainstream sinus flow and diverticular vortex decreased by 51.2 and 50.6%, respectively. …”
  16. 28936

    Audio_1_Retroauricular/Transcranial Color-Coded Doppler Ultrasound Approach in Junction With Ipsilateral Neck Compression on Real-Time Hydroacoustic Variation of Venous Pulsatile T... by Xiuli Gao (2036302)

    Published 2022
    “…When the ipsilateral IJV was compressed, PT disappeared, as the mean velocity of mainstream sinus flow and diverticular vortex decreased by 51.2 and 50.6%, respectively. …”
  17. 28937

    sAPPα, sAPPβ and sAPP-Fc induce Egr1 expression. by Stéphanie Chasseigneaux (231744)

    Published 2011
    “…<p>(<b>A</b>) Real time PCR for each recombinant protein added to 1DIV neurons for 50 minutes shows a 2-fold increased expression of Egr1 compared to controls (Ctrl). …”
  18. 28938

    Variation in actuarial senescence does not reflect life span variation across mammals by Guillaume Péron (655312)

    Published 2019
    “…Variation in life span was increasingly driven by the intensity of actuarial senescence and decreasingly driven by prime-age adult mortality from small to large species because of changes in the elasticity of life span to these parameters, even if all the adult survival parameters consistently exhibited a canalization pattern of weaker variability among long-lived species than among short-lived ones. …”
  19. 28939

    Dataset for: The impact of exercise intensity on whole body and adipose tissue metabolism during energy restriction in sedentary overweight men and postmenopausal women by Jean-Philippe Walhin (3218595)

    Published 2017
    “…Insulinaemic responses to a standard glucose load decreased similarly at follow-up relative to baseline in VIG (∆ 8.6 ± 15.4 nmol.120min.l-1) and MOD (∆ 5.4 ± 8.5 nmol.120min.l-1; P<0.05). …”
  20. 28940

    PowerPoint Slides for: Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease by Martin E.R. (3859435)

    Published 2017
    “…All subjects received low-dose supplemental oral iron (50 mg daily). The primary endpoint was the mean absolute change in hemoglobin (Hb) from baseline to the end of treatment. …”